22339-45-3 Usage
Type of compound
Ethyl ester derivative of 1H-indene-1-acetic acid
Uses
Pharmaceutical and fragrance industries, production of drugs and perfumes, synthesis of pharmaceutical products
Medicinal properties
Potential anti-inflammatory and analgesic properties
Content
The chemical is an ethyl ester derivative of 1H-indene-1-acetic acid, which is a synthetic organic compound.
It is commonly used in the pharmaceutical and fragrance industries due to its medicinal and aromatic properties.
The chemical is utilized in the production of various drugs and perfumes.
It is known for its potential anti-inflammatory and analgesic properties and is used in the synthesis of various pharmaceutical products.
The chemical is important in the pharmaceutical and fragrance industries due to its versatile applications.
Check Digit Verification of cas no
The CAS Registry Mumber 22339-45-3 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,2,3,3 and 9 respectively; the second part has 2 digits, 4 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 22339-45:
(7*2)+(6*2)+(5*3)+(4*3)+(3*9)+(2*4)+(1*5)=93
93 % 10 = 3
So 22339-45-3 is a valid CAS Registry Number.
22339-45-3Relevant articles and documents
Preparation and pharmacological screening of indanethylamines related to tryptamine
Data,Taylor,Forcione
, p. 848 - 853 (1974)
-
PLANT GROWTH REGULATOR COMPOUNDS
-
Page/Page column 29; 32, (2018/04/13)
The present invention relates to relates to novel strigolactone derivatives of formula (I), to processes for preparing these derivatives including intermediate compounds, to seeds comprising these derivatives, to plant growth regulator or seed germination promoting compositions comprising these derivatives and to methods of using these derivatives in controlling the growth of plants and/or promoting the germination of seeds.
Potassium Channel Modulators
-
Page/Page column 49, (2012/05/21)
Disclosed herein are KCNQ potassium channels modulators of formula (I) wherein R1, R2, R3, R4, and R5 are as defined in the specification. Compositions comprising such compounds; and methods for treating conditions and disorders using such compounds and compositions are also described.
